FDA Panel Rejects Avastin for Breast Cancer:
Not recommended
American Cancer Society
Expert Summary
An FDA panel didn't recommend Avastin for breast cancer treatment because the drug didn't increase survival rates. Get the details here.
Deanna Durica
Expert Scorecard
Overall Expert Score
Community Reviews
Overall Community Rating:
(1 review)
Anonymous
01/17/2008
Contains very limited information on why the FDA did not approve this drug for use. Covers the fact that there were severe side effects and did not prolong life expectancy.
Add your rating:
click to select